Real-World Data: Sponsors Should Ensure US FDA Access To Patient-Level Data Upon Submission

 
• By Sue Sutter
  
Cherries
FDA BIMO inspectors want to make sure sponsors aren't cherry-picking favorable real-world data. • Source: Alamy

More from Real-World Evidence

More from Clinical Trials